Literature DB >> 11531992

Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART).

R López-Vélez, J L Casado, V Pintado.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11531992     DOI： 10.1046/j.1198-743x.2001.00270.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  14 in total

1.  Visceral leishmaniasis presenting as subcutaneous nodules in a HIV-positive patient.

Authors:  K Göbels; T Feldt; M Oette; J Richter; G Harms; M P Grobusch; M Sarbia; D Häussinger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-08       Impact factor: 3.267

2.  Epidemiology of leishmaniasis in Spain based on hospitalization records (1997-2008).

Authors:  Ruth Gil-Prieto; Stefan Walter; Jorge Alvar; Angel Gil de Miguel
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 3.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis.

Authors:  José M Ramos; Rafael León; Esperanza Merino; Marta Montero; Asunción Aljibe; Marino Blanes; Sergio Reus; Vicente Boix; Miguel Salavert; Joaquín Portilla
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

5.  Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.

Authors:  Francesco Di Masi; Tamara Ursini; Maria Donata Iannece; Leonardo Chianura; Francesco Baldasso; Giuseppe Foti; Pietro Di Gregorio; Angelo Casabianca; Nunzio Storaci; Luciano Nigro; Claudia Colomba; Maria Grazia Marazzi; Giovanni Todaro; Giacinta Tordini; Giacomo Zanelli; Giovanni Cenderello; Nicola Acone; Ennio Polilli; Simona Migliore; Paolo Almi; Eligio Pizzigallo; Evangelista Sagnelli; Francesco Mazzotta; Rosario Russo; Lamberto Manzoli; Giustino Parruti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

6.  High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load.

Authors:  Joanna R Santos-Oliveira; Carmem B W Giacoia-Gripp; Priscilla Alexandrino de Oliveira; Valdir S Amato; Jose Ângelo L Lindoso; Hiro Goto; Manoel P Oliveira-Neto; Marise S Mattos; Beatriz Grinsztejn; Mariza G Morgado; Alda M Da-Cruz
Journal:  BMC Infect Dis       Date:  2010-12-20       Impact factor: 3.090

Review 7.  Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.

Authors:  Gláucia F Cota; Marcos R de Sousa; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

8.  Risk Factors of Leishmania Infection among HIV-Infected Patients in Trang Province, Southern Thailand: A Study on Three Prevalent Species.

Authors:  Sakarn Charoensakulchai; Lertwut Bualert; Jipada Manomat; Mathirut Mungthin; Saovanee Leelayoova; Peerapan Tan-Ariya; Suradej Siripattanapipong; Tawee Naaglor; Phunlerd Piyaraj
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

9.  Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy.

Authors:  Giovanni Cenderello; Ambra Pasa; Andrea Dusi; Chiara Dentone; Federica Toscanini; Nicoletta Bobbio; Elisabetta Bondi; Valerio Del Bono; Manuela Izzo; Giovanni Riccio; Marco Anselmo; Raffaella Giacchino; Maria Grazia Marazzi; Gabriella Pagano; Giovanni Cassola; Claudio Viscoli; Giuseppe Ferrea; Andrea De Maria
Journal:  BMC Infect Dis       Date:  2013-05-30       Impact factor: 3.090

10.  Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.

Authors:  Johan van Griensven; Koert Ritmeijer; Lutgarde Lynen; Ermias Diro
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.